Laura Shelton, MD
Gynecology · Corpus Christi, TXNPI 1760457014
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (39.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 62.9% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2023 at $5,521 and has fallen 77.2% since, to $1,260 in 2025. Among gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $135.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Coloplast$5K
- AbbVie$562
- Mayne Pharma Commercial LLC$272
- Astellas Pharma US Inc$270
- Amgen$250
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$1,6958%
- Travel & lodging$5,70426%
- Food & beverage$5,44725%
- Education$8,63639%
- Gifts$3902%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 26 | $13,766 |
| Coloplast | 26 | $4,665 |
| AbbVie | 17 | $562 |
| Mayne Pharma Commercial LLC | 7 | $272 |
| Astellas Pharma US Inc | 6 | $270 |
| Amgen | 4 | $250 |
| Smith+Nephew | 3 | $184 |
| Exeltis, USA Inc. | 5 | $182 |
| Coopersurgical, Inc. | 4 | $180 |
| Hologic Sales And Service, LLC | 6 | $166 |
| Merck | 9 | $159 |
| Myovant Sciences Inc. | 3 | $134 |
| Davol Inc. | 2 | $133 |
| Sumitomo Pharma America, Inc. | 7 | $130 |
| Pacira Pharmaceuticals Incorporated | 2 | $129 |
| Duchesnay USA Incorporated | 12 | $109 |
| Organon | 4 | $84 |
| Femselect Inc. | 1 | $63 |
| Acessa Health Inc. | 1 | $55 |
| Medtronic | 1 | $49 |
| Dexcom, Inc. | 2 | $39 |
| Evofem Biosciences, Inc. | 2 | $36 |
| Kerecis Limited | 1 | $36 |
| Conmed Corporation | 1 | $35 |
| Integra Lifesciences Corporation | 1 | $31 |
| Sage Therapeutics, LLC | 2 | $29 |
| Bayer | 1 | $24 |
| Terumo Medical Corporation | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Exact Sciences | 1 | $17 |
| BD | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
| Millicent US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$12,415
- RESTORELLE$2,214
- ALTIS$1,684
- DAVINCI XI$1,000
- Saffron$145
- Stravix$131
- EVENITY$124
- ARISTA AH FLEXITIP$118
- Advincula Delineator Uterine Manipulator$115
- Twirla$112
- Slynd$112
- Orilissa$108
- EXPAREL$105
- ORIAHNN$101
- NEXTSTELLIS$101
How this compares
$21,871 in reported general payments places this provider in the 95th percentile of 161 gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 40 | $22,863 |
| GemtesaVibegron | 12 | $8,235 |
| YuvafemEstradiol | 19 | $2,447 |
| Estradiol | 67 | $1,722 |
| ValacyclovirValacyclovir Hcl | 27 | $756 |
| ProgesteroneProgesterone, Micronized | 18 | $646 |
| Solifenacin Succinate | 12 | $420 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $341 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $191 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $188 |
| Triamcinolone Acetonide | 52 | $166 |
| Acyclovir | 14 | $138 |
| Nystatin | 17 | $126 |
| Escitalopram Oxalate | 17 | $83 |
| Fluconazole | 17 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $270 | $22,86340 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $130 | $8,23512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 161 gynecology providers in Texas.
Other gynecology in Corpus Christi
- Charles EubankCorpus Christi$51K
- Richard FarnamEl Paso$1.2M
- Jessica ShepherdDallas$809K
- Linda LacyEl Paso$627K
- John WhitfieldFort Worth$141K
- Robert ZurawinHouston$61K
- Tiffany JacksonGarland$50K
- Cynthia Chaparro-KruegerAustin$41K
- Nicolas XydasHouston$19K
- Scotty HermannWaco$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.